StonvexLoading…
StonvexStonvexStonvexCore line items from HKHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $72.85M | $55.81M | $47.26M | $2.98M |
Operating Income | $11.08M | $-15.06M | $-1.78M | $-9.91M |
Net Income | $5.12M | $92.47M | $-4.49M | $-8.85M |
EPS (Diluted) | $0.27 | $5.07 | $-0.25 | $-0.70 |
Total Assets | $2.00B | $2.03B | $1.12B | $10.73M |
Total Liabilities | $97.41M | $147.69M | $28.80M | $7.91M |
Cash & Equivalents | $36.88M | $14.45M | $10.48M | $49.00K |
Free Cash Flow OCF − CapEx | $-43.38M | $11.79M | $25.38M | Not available |
Shares Outstanding | 18.64M | 18.64M | 17.98M | 12.80M |